Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: Our backs to the wall.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 11292882.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Staphylococcus aureus is responsible for many nosocomial and community-acquired infections. Its evolving resistance to traditional antimicrobial chemotherapy and emerging prevalence outside of the healthcare environment are serious concerns. This review of the changing epidemiology of methicillin-resistant S. aureus, the emergence of vancomycin (glycopeptide)-resistant isolates, and the mechanisms of resistance to beta-lactams and glycopeptides provides an update for clinicians regarding effective strategies for treatment.
Medical subject headings
- Anti-Bacterial Agents
- Staphylococcal Infections
- Staphylococcus aureus